Latest news

7 November 2026

argenx: Phase 3 ALKIVIA shows efgartigimod delivers rapid, sustained benefit in autoimmune myositis

Phase 3 ALKIVIA met primary and key secondary endpoints in combined IMNM and DM; argenx will file an sBLA for IMNM by end‑2026 following Breakthrough Therapy designation.
7 November 2026

Johnson & Johnson: DAHLIAS Phase 2 finds mouth dryness is top-priority symptom for Sjögren’s patients

Exit interviews found 96% reported mouth dryness and linked symptom relief to better daily functioning; Phase 2 saliva gains with nipocalimab helped shape the Phase 3 DAFFODIL design.
7 November 2026

Johnson & Johnson: ICOTYDE improves disease activity in biologic‑naïve psoriatic arthritis

Phase 3 ICONIC‑PsA 1: 58% ACR20 vs 41% placebo at Week 16 for oral IL‑23R blocker; responses increased by Week 24 and safety was consistent.
6 November 2026

CVMP meeting highlights 3–5 November 2026

Positive opinions for multiple veterinary authorisations including Scovella (velagliflozin) under the limited market framework; vaccine variations; JIACRA V adoption and regulatory consultations.
6 November 2026

Fluor Q3 2026: record $10.9B awards and $34.3B backlog

Revenue rose 10% to $3.7B; GAAP EPS $1.16 and adjusted EPS $0.77. Q3 buybacks $300M; affirms 2026 adjusted EBITDA guidance of $500–$525M.
6 November 2026

SOCAR and Honeywell Technologies sign global framework for energy digitalisation and automation

First-of-its-kind global framework to enable future supply of products, services and software supporting digital transformation, automation and resilience across domestic and international energy assets.
6 November 2026

Novo Nordisk: real‑world data link Wegovy 2.4 mg to lower liver enzymes, weight and HbA1c in adults with MASH

Real‑world cohorts showed Wegovy 2.4 mg was associated with larger reductions in body weight, AST/ALT, and HbA1c versus resmetirom or no semaglutide in adults with MASH.
6 November 2026

AkzoNobel and Axalta secure European Commission conditional clearance

EU clearance granted conditionally after proposal to divest a European vehicle refinish business; merger will form a ~$17bn coatings group and targets completion in early 2027.
6 November 2026

RWE and Kawasaki begin 34 MW hydrogen-capable gas turbine trials in Lingen

Europe’s largest fully hydrogen‑compatible gas turbine will be trialled in Lingen, testing up to 100% hydrogen fuel supplied by on‑site electrolysers to inform flexible backup generation.
6 November 2026

LOTTE Chemical restructures basic chemicals and expands specialty businesses after Q3 2026 loss

Q3 revenue KRW 5.3951T, operating loss KRW 281.4B; Daesan JV launched; Yeosu integration targeted H1 next year; Yulchon compounding capacity 500,000 t/yr with new specialty line in Q1.
6 November 2026

Sasol rolls out Turbodiesel ULS 10ppm across 20 Western Cape sites

20 retail sites in the Western Cape will replace 50ppm diesel with 10ppm ULS diesel, supporting modern engines and advanced exhaust after‑treatment systems.
6 November 2026

LAT Nitrogen Linz and SKW Piesteritz partner with KBR to modernise ammonia units

Joint revamp targets ~10% lower specific energy at SKW unit 2 and major natural gas savings at LAT unit 2 via KBR KRES reformer; contracts signed end-September 2026.
6 November 2026

Lilly and Hims & Hers broaden access to Lilly’s Zepbound and Foundayo

Eligible patients can obtain Zepbound (tirzepatide) and Foundayo (orforglipron) via Hims & Hers telehealth with self-pay prices from $149/month for Foundayo and $299/month for Zepbound.
6 November 2026

European Court of Justice upholds STOT RE 2 classification for silanamine in Evonik case

Confirms read‑across is acceptable in CLH procedures, allowing hazard assessments using data from comparable particulate substances and clarifying particle‑size treatment.
6 November 2026

MOL Group posts USD 1,250m profit before tax in Q3 2026

Strong refining margins and higher gas prices lifted results, while petrochemicals weakness and regulated fuel pricing weighed on retail performance.
6 November 2026

Sinopec’s Hou Qijun at 9th CIIE opening and theme forum

Chairman sets priorities on supply‑chain resilience, green development and open innovation; Sinopec signs US$41.3bn in procurement deals with 37 partners.
6 November 2026

ADNOC to supply Gujarat Energy up to 4 million tonnes LNG over 10 years

First sale from XRG’s international portfolio via a new global LNG trading platform; deliveries start in 2028 and the platform targets 47 mtpa beyond 2030.
5 November 2026

Johnson & Johnson wins FDA accelerated approval for RYBREVANT FASPRO in recurrent/metastatic HNSCC

Subcutaneous bispecific (amivantamab + hyaluronidase) approved for adults with recurrent/metastatic head and neck squamous cell carcinoma after platinum and anti‑PD‑(L)1 therapy.
5 November 2026

Lilly showcases retatrutide, Taltz (ixekizumab) and Zepbound (tirzepatide) data at ACR Convergence 2026

Phase 3 TRIUMPH trials showed retatrutide cut knee pain by up to 75.8% with some patients pain‑free; TOGETHER‑PsA found ixekizumab plus tirzepatide raised ACR50 to 43.7% at 52 weeks.
5 November 2026

UPM and Sappi submit remedies in EC review of graphic paper joint venture

Remedies cover capacity optimisation, customer safeguards and investments in decarbonisation while the European Commission assesses the proposed joint venture; decision expected by year-end.
5 November 2026

AFYREN and MINASOLVE partner to commercialize industrial-scale biobased fragrance molecules

Partnership to market selected biobased fragrance molecules offering natural, traceable origins, lower carbon footprint and stable costs for cosmetics and beauty markets.
5 November 2026

Agilyx’s GreenDot acquires 50% of Valorie (Léko) to expand European recycling platform

Deal includes an initial EUR 4m at closing plus conditional milestone payments, grants preferred feedstock access and EPR services, Léko had EUR 42m revenue in 2025; closed 5 Nov 2026.
5 November 2026

Aemetis Q3 2026: Revenue +49%, Net Income $5.2M, Adjusted EBITDA $24.8M

Dairy RNG output and a September 45Z model revision lifted tax‑credit revenue and profitability while Keyes MVR progress and two new digesters expand capacity.
5 November 2026

BASF, Stellantis and L&L Products win SPE Innovation Award for 2027 Jeep Grand Cherokee tunnel reinforcement

13% lighter than prior design, 40% lower product carbon footprint, 20% higher peak loading, and uses a 60% post‑industrial recycled PA6 in the tunnel reinforcement.
5 November 2026

BASF, Ford and Supavut win SPE award for Ultramid PA6 bezels on 2026 Ford Everest

Paint-free, high-gloss door-handle bezels use a single-material Ultramid Deep Gloss PA6 blend to enable standard single-step injection molding and easier end-of-life recovery.
5 November 2026

Amgen: Repatha lowers heart attack risk 20% vs ezetimibe in large real‑world cohort

Real‑world analysis of 544,103 adults with ASCVD followed up to four years; comparative non‑statin outcomes evidence to inform treatment choices and LDL‑C goal attainment.
5 November 2026

Genmab nine-month 2026 results: revenue up 22%, epcoritamab approved, Phase‑3 readouts positive

Revenue rose 22% to $3,238m; epcoritamab approved in Europe and Japan; two Phase‑3 starts for petosemtamab in CRC; multiple Phase‑3 topline readouts were positive.
5 November 2026

ORLEN Q3 2026 results: lowest fuel prices in the EU support Polish economy

Q3 LIFO EBITDA PLN 14.8bn, revenue PLN 80.1bn, net profit PLN 5.6bn; PLN 7.8bn invested; Afrodite appraisal lifts ORLEN’s gas share above 4bn m³; negative net debt-to-EBITDA.
5 November 2026

GSK presents Hibsago and efimosfermin results at AASLD 2026

Long-term Hibsago data and efimosfermin Phase II fibrosis signals headline 21 abstracts at AASLD (5–9 Nov, Denver). Findings span functional cure durability, HBsAg predictors and retreatment modelling.
5 November 2026

Iberdrola tests 100% renewable-steam electrification at Bayer's Asturias plant

Uses molten-salt thermal storage, a 15 MW PPA and 2.5 MW PV; avoids ~6,500 tCO2/yr; >€18m investment and Spain's first large-scale heat-electrification project with storage.

Next →